These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 25866337)

  • 1. Field study of fecal excretion as a decision support tool in response to silent reintroduction of wild-type poliovirus 1 into Israel.
    Moran-Gilad J; Mendelson E; Burns CC; Bassal R; Gdalevich M; Sofer D; Oberste MS; Shulman LM; Kaliner E; Hindiyeh M; Mor O; Shahar L; Iber J; Yishay R; Manor J; Lev B; Gamzu R; Grotto I
    J Clin Virol; 2015 May; 66():51-5. PubMed ID: 25866337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a real time quantitative reverse transcription-polymerase chain reaction (qRT-PCR) assay for investigation of wild poliovirus type 1-South Asian (SOAS) strain reintroduced into Israel, 2013 to 2014.
    Hindiyeh MY; Moran-Gilad J; Manor Y; Ram D; Shulman LM; Sofer D; Mendelson E
    Euro Surveill; 2014 Feb; 19(7):20710. PubMed ID: 24576470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis and characterization of wild poliovirus type 1 during sustained transmission in a population with >95% vaccine coverage, Israel 2013.
    Shulman LM; Martin J; Sofer D; Burns CC; Manor Y; Hindiyeh M; Gavrilin E; Wilton T; Moran-Gilad J; Gamzo R; Mendelson E; Grotto I; ;
    Clin Infect Dis; 2015 Apr; 60(7):1057-64. PubMed ID: 25550350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Laboratory challenges in response to silent introduction and sustained transmission of wild poliovirus type 1 in Israel during 2013.
    Shulman LM; Mendelson E; Anis E; Bassal R; Gdalevich M; Hindiyeh M; Kaliner E; Kopel E; Manor Y; Moran-Gilad J; Ram D; Sofer D; Somekh E; Tasher D; Weil M; Gamzu R; Grotto I
    J Infect Dis; 2014 Nov; 210 Suppl 1():S304-14. PubMed ID: 25316849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intensified environmental surveillance supporting the response to wild poliovirus type 1 silent circulation in Israel, 2013.
    Manor Y; Shulman LM; Kaliner E; Hindiyeh M; Ram D; Sofer D; Moran-Gilad J; Lev B; Grotto I; Gamzu R; Mendelson E
    Euro Surveill; 2014 Feb; 19(7):20708. PubMed ID: 24576473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral and fecal polio vaccine excretion following bOPV vaccination among Israeli infants.
    Chorin O; Markovich MP; Avramovich E; Rahmani S; Sofer D; Weil M; Shohat T; Chorin E; Tasher D; Somekh E
    Vaccine; 2023 Jun; 41(28):4144-4150. PubMed ID: 37268556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health response to the silent reintroduction of wild poliovirus to Israel, 2013-2014.
    Moran-Gilad J; Kaliner E; Gdalevich M; Grotto I
    Clin Microbiol Infect; 2016 Dec; 22 Suppl 5():S140-S145. PubMed ID: 28034372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of the silent polio outbreak in Rahat, Israel, based on modeling of environmental surveillance data.
    Brouwer AF; Eisenberg JNS; Pomeroy CD; Shulman LM; Hindiyeh M; Manor Y; Grotto I; Koopman JS; Eisenberg MC
    Proc Natl Acad Sci U S A; 2018 Nov; 115(45):E10625-E10633. PubMed ID: 30337479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling options to manage type 1 wild poliovirus imported into Israel in 2013.
    Kalkowska DA; Duintjer Tebbens RJ; Grotto I; Shulman LM; Anis E; Wassilak SG; Pallansch MA; Thompson KM
    J Infect Dis; 2015 Jun; 211(11):1800-12. PubMed ID: 25505296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular epidemiology of silent introduction and sustained transmission of wild poliovirus type 1, Israel, 2013.
    Shulman LM; Gavrilin E; Jorba J; Martin J; Burns CC; Manor Y; Moran-Gilad J; Sofer D; Hindiyeh MY; Gamzu R; Mendelson E; Grotto I;
    Euro Surveill; 2014 Feb; 19(7):20709. PubMed ID: 24576471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the Fast Testing Strategy for identifying the wild poliovirus I].
    Gong C; Luo M; Chen M; Zhang TG; Zhang HR; Wang YM; Li RQ; Dong M; Chen WX; Chen LJ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2012 Jul; 33(7):726-9. PubMed ID: 22968025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of a novel real-time PCR assay to detect oral polio vaccine shedding and reversion in stool and sewage samples after a mexican national immunization day.
    Troy SB; Ferreyra-Reyes L; Huang C; Mahmud N; Lee YJ; Canizales-Quintero S; Flaster H; Báez-Saldaña R; García-García L; Maldonado Y
    J Clin Microbiol; 2011 May; 49(5):1777-83. PubMed ID: 21411577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of asymptomatic poliovirus infection in older children and adults in northern India: analysis of contact and enhanced community surveillance, 2009.
    Mach O; Verma H; Khandait DW; Sutter RW; O'Connor PM; Pallansch MA; Cochi SL; Linkins RW; Chu SY; Wolff C; Jafari HS
    J Infect Dis; 2014 Nov; 210 Suppl 1(0 1):S252-8. PubMed ID: 25316843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time reverse transcription-polymerase chain reaction assays for identification of wild poliovirus 1 & 3.
    Sharma DK; Nalavade UP; Deshpande JM
    Indian J Med Res; 2015 Oct; 142(4):471-8. PubMed ID: 26609040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of vaccine-derived polioviruses in stools of immunodeficient children in South Africa.
    Pavlov DN; Van Zyl WB; Van Heerden J; Kruger M; Blignaut L; Grabow WO; Ehlers MM
    J Appl Microbiol; 2006 Dec; 101(6):1367-79. PubMed ID: 17105568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessing the individual risk of fecal poliovirus shedding among vaccinated and non-vaccinated subjects following national health weeks in Mexico.
    Ferreyra-Reyes L; Cruz-Hervert LP; Troy SB; Huang C; Sarnquist C; Delgado-Sánchez G; Canizales-Quintero S; Holubar M; Ferreira-Guerrero E; Montero-Campos R; Rodríguez-Álvarez M; Mongua-Rodriguez N; Maldonado Y; García-García L
    PLoS One; 2017; 12(10):e0185594. PubMed ID: 29023555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sabin and wild polioviruses from apparently healthy primary school children in northeastern Nigeria.
    Baba MM; Oderinde BS; Patrick PZ; Jarmai MM
    J Med Virol; 2012 Feb; 84(2):358-64. PubMed ID: 22170559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of poliovirus shedding following oral vaccination as measured by quantitative reverse transcription-PCR versus culture.
    Taniuchi M; Begum S; Uddin MJ; Platts-Mills JA; Liu J; Kirkpatrick BD; Chowdhury AH; Jamil KM; Haque R; Petri WA; Houpt ER
    J Clin Microbiol; 2015 Jan; 53(1):206-11. PubMed ID: 25378579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of prolonged and chronic poliovirus excretion among persons with primary immune deficiency disorders in Sri Lanka.
    de Silva R; Gunasena S; Ratnayake D; Wickremesinghe GD; Kumarasiri CD; Pushpakumara BA; Deshpande J; Kahn AL; Sutter RW
    Vaccine; 2012 Dec; 30(52):7561-5. PubMed ID: 23099333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress toward poliomyelitis eradication--Nigeria, January 2008-July 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(41):1150-4. PubMed ID: 19847150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.